Entera Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Entera Bio and other ETFs, options, and stocks.About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2.
CEOMiranda J. Toledano
CEOMiranda J. Toledano
Employees20
Employees20
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2009
Founded2009
Employees20
Employees20
ENTX Key Statistics
Market cap106.40M
Market cap106.40M
Price-Earnings ratio-9.07
Price-Earnings ratio-9.07
Dividend yield—
Dividend yield—
Average volume357.26K
Average volume357.26K
High today$2.37
High today$2.37
Low today$2.15
Low today$2.15
Open price$2.22
Open price$2.22
Volume199.18K
Volume199.18K
52 Week high$2.95
52 Week high$2.95
52 Week low$1.50
52 Week low$1.50
ENTX News
TipRanks 5d
Entera Bio presents clinical data from EB613 Phase 2 trialEntera Bio (ENTX) reported new clinical data from a post-hoc analysis of its Phase 2 trial of EB613, at the 2025 North American Menopause Society Annual Meeting...
People also own
Based on the portfolios of people who own ENTX. This list is generated using Robinhood data, and it’s not a recommendation.